Results 251 to 260 of about 6,151,641 (285)

Modeling, Evaluation, and In Vivo Estimation of Muscle Cell Diameter With the Random Permeable Barrier Model: Correlation With Subject Characteristics and Isometric Torque. [PDF]

NMR Biomed
Froeling M, Brenninkmeijer R, van der Woude DR, Bartels B, Heskamp L.   +4 more
europepmc   +1 more source

РазÑабоÑка безопаÑной инÑоÑмаÑионной ÑиÑÑÐµÐ¼Ñ Ð´Ð»Ñ ÑпÑÐ°Ð²Ð»ÐµÐ½Ð¸Ñ Ð³Ð¾ÑÑдаÑÑÑвеннÑм мÑзеем "ÐÑмиÑаж"

, 2016
Виктория Шупик
openalex   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. [PDF]

Diabetes Care
Mann JFE, Marx N, Deanfield JE, Emerson SS, Inzucchi SE, McGuire DK, Mulvagh SL, Pop-Busui R, Poulter NR, Engelmann MDM, Hovingh GK, Belmar N, Idorn T, Jeppesen OK, Birkenfeld AL, Amod A, Mankovsky B, Desouza C, Gorgojo-Martinez JJ, Arechavaleta R, Tu ST, Buse JB, SOUL Study Group* .   +22 more
europepmc   +1 more source

ÐÑинÑипи лÑкÑвалÑÐ½Ð¾Ñ ÑакÑики пÑи гоÑÑÑо-кÑовоÑоÑÐ¸Ð²Ð¸Ñ Ð·Ð»Ð¾ÑкÑÑÐ½Ð¸Ñ Ð¿ÑÑÐ»Ð¸Ð½Ð°Ñ ÑлÑнка

, 2015
П. В. Іванчов
openalex   +2 more sources

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Notch signaling stabilizes lengths of motile cilia in multiciliated cells in the lung. [PDF]

Life Sci Alliance
Joy N, Deshpande A, Lingamallu SM, Prabantu VM, Naveenkumar CN, Bharathkumar K, Bhat S, Alvarado-Martinez Z, Livraghi-Butrico A, Hagood JS, Boucher RC, Lafkas D, Byrd KM, Narayanan S, Shandil RK, Guha A.   +15 more
europepmc   +1 more source

ÐоÑвÑд ÑÑÑÑÑгÑÑного лÑкÑÐ²Ð°Ð½Ð½Ñ Ð°Ð´ÐµÐ½Ð¾Ð¼Ð°ÑÐ¾Ð·Ð½Ð¸Ñ Ð¿Ð¾Ð»ÑпÑв пÑÑÐ¼Ð¾Ñ ÐºÐ¸Ñки

, 2015
Олексій Володимирович Новицький, І. М. Шевчук, А. Л. Шаповал   +2 more
openalex   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Apelin-13 confers Neuropeptide Y-mediated neuroprotection and preserves learning and allocentric memory in D-glutamic acid-induced excitotoxicity in rats. [PDF]

Mol Neurobiol
Oruc KY, Oruc A, Arslan R, Diriarin FP, Mengi M, Tanriverdi G, Yanar K, Ozeren Eser M, Agturk G, Sonkurt AI, Guler B, Seymen HO.   +11 more
europepmc   +1 more source